Ankylosing spondylitis early diagnosis, early treatment

Chun Hsiung Chen, Hsien Tzung Liao, Toong Hua Liang, Chung Tei Chou

Research output: Contribution to journalArticle

Abstract

Ankylosing spondylitis is a common chronic inflammatory rheumatic disease, characterized by axial joint inflammation, peripheral arthritis, and enthesopathy. It primarily affect young male, and has strong linkage with HLA-B27. Persistent inflammation could lead to the bony growth or syndesmophyte, ankylosing of the adjacent vertebral body, and loss of functional ability. Exercise and nonsteroidal anti-inflammatory drugs (NSAIDs) are the standard therapy for the patients with ankylosing spondylitis. Sulfasalazine is helpful in the patients with peripheral arthritis. Local steroids injections are also widely used in refractory enthesopathy and peripheral arthritis. The most important progress in the treatment of ankylosing spondylitis is the newly development of anti-tumor necrosis factor-α (TNF-α) drugs. Patient's can achieve rapid, significant and sustained improvement with these biologic agent.

Original languageEnglish
Pages (from-to)481-490
Number of pages10
JournalJournal of Internal Medicine of Taiwan
Volume19
Issue number6
Publication statusPublished - Dec 2008

Fingerprint

Ankylosing Spondylitis
Arthritis
Early Diagnosis
Inflammation
HLA-B27 Antigen
Sulfasalazine
Biological Factors
Rheumatic Diseases
Anti-Inflammatory Agents
Therapeutics
Tumor Necrosis Factor-alpha
Joints
Steroids
Exercise
Drug Therapy
Injections
Growth
Pharmaceutical Preparations
Enthesopathy

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Chen, C. H., Liao, H. T., Liang, T. H., & Chou, C. T. (2008). Ankylosing spondylitis early diagnosis, early treatment. Journal of Internal Medicine of Taiwan, 19(6), 481-490.

Ankylosing spondylitis early diagnosis, early treatment. / Chen, Chun Hsiung; Liao, Hsien Tzung; Liang, Toong Hua; Chou, Chung Tei.

In: Journal of Internal Medicine of Taiwan, Vol. 19, No. 6, 12.2008, p. 481-490.

Research output: Contribution to journalArticle

Chen, CH, Liao, HT, Liang, TH & Chou, CT 2008, 'Ankylosing spondylitis early diagnosis, early treatment', Journal of Internal Medicine of Taiwan, vol. 19, no. 6, pp. 481-490.
Chen CH, Liao HT, Liang TH, Chou CT. Ankylosing spondylitis early diagnosis, early treatment. Journal of Internal Medicine of Taiwan. 2008 Dec;19(6):481-490.
Chen, Chun Hsiung ; Liao, Hsien Tzung ; Liang, Toong Hua ; Chou, Chung Tei. / Ankylosing spondylitis early diagnosis, early treatment. In: Journal of Internal Medicine of Taiwan. 2008 ; Vol. 19, No. 6. pp. 481-490.
@article{b2974a9306c6447c80ac2c3148591f47,
title = "Ankylosing spondylitis early diagnosis, early treatment",
abstract = "Ankylosing spondylitis is a common chronic inflammatory rheumatic disease, characterized by axial joint inflammation, peripheral arthritis, and enthesopathy. It primarily affect young male, and has strong linkage with HLA-B27. Persistent inflammation could lead to the bony growth or syndesmophyte, ankylosing of the adjacent vertebral body, and loss of functional ability. Exercise and nonsteroidal anti-inflammatory drugs (NSAIDs) are the standard therapy for the patients with ankylosing spondylitis. Sulfasalazine is helpful in the patients with peripheral arthritis. Local steroids injections are also widely used in refractory enthesopathy and peripheral arthritis. The most important progress in the treatment of ankylosing spondylitis is the newly development of anti-tumor necrosis factor-α (TNF-α) drugs. Patient's can achieve rapid, significant and sustained improvement with these biologic agent.",
author = "Chen, {Chun Hsiung} and Liao, {Hsien Tzung} and Liang, {Toong Hua} and Chou, {Chung Tei}",
year = "2008",
month = "12",
language = "English",
volume = "19",
pages = "481--490",
journal = "Journal of Internal Medicine of Taiwan",
issn = "1016-7390",
publisher = "臺灣內科醫學會",
number = "6",

}

TY - JOUR

T1 - Ankylosing spondylitis early diagnosis, early treatment

AU - Chen, Chun Hsiung

AU - Liao, Hsien Tzung

AU - Liang, Toong Hua

AU - Chou, Chung Tei

PY - 2008/12

Y1 - 2008/12

N2 - Ankylosing spondylitis is a common chronic inflammatory rheumatic disease, characterized by axial joint inflammation, peripheral arthritis, and enthesopathy. It primarily affect young male, and has strong linkage with HLA-B27. Persistent inflammation could lead to the bony growth or syndesmophyte, ankylosing of the adjacent vertebral body, and loss of functional ability. Exercise and nonsteroidal anti-inflammatory drugs (NSAIDs) are the standard therapy for the patients with ankylosing spondylitis. Sulfasalazine is helpful in the patients with peripheral arthritis. Local steroids injections are also widely used in refractory enthesopathy and peripheral arthritis. The most important progress in the treatment of ankylosing spondylitis is the newly development of anti-tumor necrosis factor-α (TNF-α) drugs. Patient's can achieve rapid, significant and sustained improvement with these biologic agent.

AB - Ankylosing spondylitis is a common chronic inflammatory rheumatic disease, characterized by axial joint inflammation, peripheral arthritis, and enthesopathy. It primarily affect young male, and has strong linkage with HLA-B27. Persistent inflammation could lead to the bony growth or syndesmophyte, ankylosing of the adjacent vertebral body, and loss of functional ability. Exercise and nonsteroidal anti-inflammatory drugs (NSAIDs) are the standard therapy for the patients with ankylosing spondylitis. Sulfasalazine is helpful in the patients with peripheral arthritis. Local steroids injections are also widely used in refractory enthesopathy and peripheral arthritis. The most important progress in the treatment of ankylosing spondylitis is the newly development of anti-tumor necrosis factor-α (TNF-α) drugs. Patient's can achieve rapid, significant and sustained improvement with these biologic agent.

UR - http://www.scopus.com/inward/record.url?scp=58149506231&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=58149506231&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:58149506231

VL - 19

SP - 481

EP - 490

JO - Journal of Internal Medicine of Taiwan

JF - Journal of Internal Medicine of Taiwan

SN - 1016-7390

IS - 6

ER -